Disrupting this degradation pathway by either inhibiting ASB11 or knocking down Cul5 stabilizes Bik, which has been shown to increase cell apoptosis, supporting a therapeutic angle for cancer treatments where enhanced Bik stability may be desirable [133]. This evidence concerns the gene ASB11 and cancer.